Hanze Zhang
First Affiliated Hospital of Xi'an Jiaotong University(CN)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiac pacing and defibrillation studies, Cardiac electrophysiology and arrhythmias, Cardiovascular Function and Risk Factors, Blood Pressure and Hypertension Studies
Most-Cited Works
- → Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil(2021)17 cited
- → Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure(2020)14 cited
- → Evaluation of drug‐drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically‐based pharmacokinetic model(2021)10 cited
- → Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator(2021)8 cited
- → Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects(2021)7 cited
- → The Impact of COVID-19 on Hospitals Financial Performance: Evidence from California Hospitals(2022)7 cited
- → Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug‐Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open‐Label Studies in Healthy Subjects(2021)7 cited
- → Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil(2021)7 cited
- → Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects(2021)4 cited
- → Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy Subjects(2021)3 cited